Tennessee Oncology NASH - SCRI - PPDS — Nashville, Tennessee

Tennessee Oncology NASH - SCRI - PPDS is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.

Tennessee Oncology NASH - SCRI - PPDS has participated in 5 clinical trials with 1 currently active.

Therapeutic areas: Myelodysplastic Syndrome, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute.

Sponsors: Takeda, Bristol-Myers Squibb, Pfizer.

Sponsor Feasibility Report

Trust Score: 73/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Tennessee Oncology NASH - SCRI - PPDS?

Tennessee Oncology NASH - SCRI - PPDS has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Tennessee Oncology NASH - SCRI - PPDS conducted?

Tennessee Oncology NASH - SCRI - PPDS has 5 clinical trials on record, with 1 currently active. Their work covers Myelodysplastic Syndrome, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute.

Is Tennessee Oncology NASH - SCRI - PPDS accredited by Crixeo Health?

Yes — Tennessee Oncology NASH - SCRI - PPDS holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Tennessee Oncology NASH - SCRI - PPDS?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.